Trending News
News
News
Oxford Gene Technology in Collaboration with Optra Systems to Develop Analysis Software
The collaboration establishes to develop software to visualize and analyze data generated from high resolution scanners, is now in the testing phase.
News
Roche NimbleGen Microarrays Selected for the Neuromuscular Disorder -Chip Consortium
The NMD-Chip Consortium selects Roche NimbleGen microarrays to accelerate and simplify genetic research of neuromuscular disorders.
News
From eResearchTechnology to ERT
The Philadelphia-based company unveils its new identity and commits to ‘Getting It Done, Right’.
News
Applied Biosystems and BCM Summarize Contributions to First Data Release of 1000 Genomes Project
SOLiD™ System generates more than 400 gigabases of mappable sequence data for project.
News
The BNC Creates the London Nanotube™ - the Smallest Map of the London Underground
BNC researchers have produced a miniaturized version of the London tube map, measuring only 2x3 mm; about the size of a pinhead.
News
Fox Chase Cancer Center Adopts Nexus Copy Number and Nexus Expression
The center's Keystone Program in Blood Cell Development and Cancer gains a site license for two bioinformatics software programs from BioDiscovery.
News
Washington University Becker Library Makes MetaCore Accessible Throughout the University
The Becker Medical Library Bioinformatics@Becker program now provides GeneGo’s data mining bioinformatics tool for researchers and students.
News
Agilent Technologies and National University of Ireland Open Biological Mass Spectrometry Facility
The facility is fully equipped with the latest mass spectrometer platforms for functional genomics, proteomics, lipidomics and metabolomics research.
News
Lab21 and BreastHealth UK Form Partnership for Breast Health Management
The partners will offer UK women personalized health management and predictive genetic testing for breast cancer risk.
News
Argenta Discovery and Almac Discovery Announce Contract Drug Discovery Collaboration in Cancer
Both the companies will work together to advance one of Almac’s portfolio of high-value cancer programmes from hit identification to development candidate.
Advertisement